Development of an electronic patient-reported outcome measure (ePROM) system to aid the management of patients with advanced chronic kidney disease.
Chronic kidney disease
Patient-reported outcomes
Symptom monitoring
Journal
Journal of patient-reported outcomes
ISSN: 2509-8020
Titre abrégé: J Patient Rep Outcomes
Pays: Germany
ID NLM: 101722688
Informations de publication
Date de publication:
08 Jul 2020
08 Jul 2020
Historique:
received:
09
01
2020
accepted:
28
06
2020
entrez:
10
7
2020
pubmed:
10
7
2020
medline:
10
7
2020
Statut:
epublish
Résumé
Effective management of patients with chronic kidney disease (CKD) relies on timely detection of clinical deterioration towards end stage kidney failure. We aimed to design an electronic Patient-Reported Outcome Measure (ePROM) system, which would allow patients with advanced CKD (pre-dialysis) to: (i) remotely self-report their symptoms using a simple and secure online platform; (ii) share the data with the clinical team in real-time via the electronic patient record to help optimise care. We adopted a staged development process which included: a systematic review of PROMs used in CKD; formation of a co-design team; prototype system design/development, user acceptance testing and refinement; finalisation of the system for testing in a pilot/feasibility trial. A co-design team was convened, including patients with lived experience of CKD; clinical team members; IT/Informatics experts; academics; and Birmingham Clinical Trials Unit representatives. A prototype system was developed and iterative changes made before finalisation during a series of operational meetings. The system allows patients to remotely self-report their symptoms; provides tailored self-management advice; allows monitoring of real-time patient ePROM data; sends automated notifications to the patient/clinical team in the advent of a severe symptom report; and incorporates longitudinal ePROM symptom data into the electronic patient record. Feasibility of the system will be evaluated as part of the National Institute for Health Research funded RePROM (Renal electronic Patient-Reported Outcome Measure) pilot trial (ISRCTN12669006). Routine ePROM collection with real-time feedback has the potential to improve outcomes and reduce health service costs. We have successfully developed a trial-ready ePROM system for advanced CKD, the feasibility of which is currently being explored in a pilot trial. Assuming feasibility is demonstrated, formal evaluation of efficacy will take place in a future multi-centre randomised controlled trial.
Sections du résumé
BACKGROUND
BACKGROUND
Effective management of patients with chronic kidney disease (CKD) relies on timely detection of clinical deterioration towards end stage kidney failure. We aimed to design an electronic Patient-Reported Outcome Measure (ePROM) system, which would allow patients with advanced CKD (pre-dialysis) to: (i) remotely self-report their symptoms using a simple and secure online platform; (ii) share the data with the clinical team in real-time via the electronic patient record to help optimise care. We adopted a staged development process which included: a systematic review of PROMs used in CKD; formation of a co-design team; prototype system design/development, user acceptance testing and refinement; finalisation of the system for testing in a pilot/feasibility trial.
RESULTS
RESULTS
A co-design team was convened, including patients with lived experience of CKD; clinical team members; IT/Informatics experts; academics; and Birmingham Clinical Trials Unit representatives. A prototype system was developed and iterative changes made before finalisation during a series of operational meetings. The system allows patients to remotely self-report their symptoms; provides tailored self-management advice; allows monitoring of real-time patient ePROM data; sends automated notifications to the patient/clinical team in the advent of a severe symptom report; and incorporates longitudinal ePROM symptom data into the electronic patient record. Feasibility of the system will be evaluated as part of the National Institute for Health Research funded RePROM (Renal electronic Patient-Reported Outcome Measure) pilot trial (ISRCTN12669006).
CONCLUSIONS
CONCLUSIONS
Routine ePROM collection with real-time feedback has the potential to improve outcomes and reduce health service costs. We have successfully developed a trial-ready ePROM system for advanced CKD, the feasibility of which is currently being explored in a pilot trial. Assuming feasibility is demonstrated, formal evaluation of efficacy will take place in a future multi-centre randomised controlled trial.
Identifiants
pubmed: 32642867
doi: 10.1186/s41687-020-00223-8
pii: 10.1186/s41687-020-00223-8
pmc: PMC7343684
doi:
Types de publication
Journal Article
Langues
eng
Pagination
55Subventions
Organisme : Department of Health
ID : PDF-2016-09-009
Pays : United Kingdom
Organisme : National Institute for Health Research
ID : PDF-2016-09-009
Références
Ann Oncol. 2017 Sep 1;28(9):2305-2311
pubmed: 28911065
Qual Life Res. 2009 Feb;18(1):109-14
pubmed: 19043804
BMJ Open. 2014 Jul 22;4(7):e005601
pubmed: 25052175
Acta Oncol. 2015 May;54(5):600-8
pubmed: 25751758
J Pain Symptom Manage. 2015 Mar;49(3):611-24
pubmed: 25135657
BMC Health Serv Res. 2017 Jun 26;17(1):439
pubmed: 28651528
Nephrol Dial Transplant. 2010 Jan;25(1):160-6
pubmed: 19717826
JAMA. 2019 Jan 22;321(3):306-307
pubmed: 30667494
Int J Nephrol Renovasc Dis. 2012;5:151-63
pubmed: 23293534
J Pain Symptom Manage. 2012 Dec;44(6):923-32
pubmed: 22795902
PLoS One. 2016 Nov 10;11(11):e0165675
pubmed: 27832126
Qual Life Res. 2012 Oct;21(8):1305-14
pubmed: 22048932
Qual Life Res. 2014 Jun;23(5):1505-13
pubmed: 24318085
Patient Educ Couns. 2009 Mar;74(3):295-301
pubmed: 19150199
Qual Life Res. 1994 Oct;3(5):329-38
pubmed: 7841967
JAMA. 2002 Dec 18;288(23):3027-34
pubmed: 12479768
JAMA. 2011 Apr 20;305(15):1553-9
pubmed: 21482743
Br J Cancer. 2002 Jan 7;86(1):51-9
pubmed: 11857011
Eur J Health Econ. 2013 Jul;14 Suppl 1:S1-3
pubmed: 23900659
J Thorac Oncol. 2019 Jun;14(6):1012-1020
pubmed: 30776447
J Clin Oncol. 2004 Feb 15;22(4):714-24
pubmed: 14966096
J Natl Cancer Inst. 2017 Sep 1;109(9):
pubmed: 28423407
Trials. 2015 May 03;16:204
pubmed: 25935741
J Clin Oncol. 2016 Feb 20;34(6):557-65
pubmed: 26644527
BMC Nephrol. 2012 Dec 13;13:170
pubmed: 23237591
Qual Life Res. 2009 Feb;18(1):115-23
pubmed: 19105048
J Ren Care. 2013 Sep;39(3):140-50
pubmed: 23826803
Comput Biol Med. 2018 Oct 1;101:120-127
pubmed: 30130638
Soc Sci Med. 2005 Feb;60(4):833-43
pubmed: 15571900
Ethn Dis. 2013 Spring;23(2):202-9
pubmed: 23530302
West J Nurs Res. 2016 Aug;38(8):1067-82
pubmed: 27026384
Hemodial Int. 2017 Apr;21(2):265-273
pubmed: 27616731
Eur J Cancer Care (Engl). 2009 Mar;18(2):156-64
pubmed: 19267731
Nephrol Dial Transplant. 2017 Apr 1;32(suppl_2):ii121-ii128
pubmed: 28201666
JAMA. 2017 Jul 11;318(2):197-198
pubmed: 28586821
BMJ Open. 2018 Oct 28;8(10):e026080
pubmed: 30373785
PLoS One. 2017 Jun 21;12(6):e0179733
pubmed: 28636678
BMJ. 2019 Jan 24;364:k5267
pubmed: 30679170